Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methadone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methadone 40mg capsules
0407020M0AABTBT
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 40mg impregnated cigarettes
0407020M0AAAGAG
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 40mg/1ml solution for injection ampoules
0407020M0AABKBK
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 40mg/5ml oral liquid
0410030C0AABHBH
|
Methadone hydrochloride (Drug Dependence) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 4mg/5ml oral liquid
0410030C0AAAZAZ
|
Methadone hydrochloride (Drug Dependence) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 50mg capsules
0407020M0AABLBL
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 50mg tablets
0407020M0AABVBV
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 50mg/2ml solution for injection ampoules
0407020M0AAA6A6
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 50mg/5ml solution for injection ampoules
0407020M0AAANAN
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 5mg/ml oral solution
0410030C0AABMBM
|
Methadone hydrochloride (Drug Dependence) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone 60mg impregnated cigarettes
0407020M0AAAXAX
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadone hydrochloride powder
0407020M0AAAFAF
|
Methadone hydrochloride (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Methadose 20mg/ml oral solution concentrate
0410030C0BBABBB
|
Methadose | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 20mg/2ml solution for injection ampoules
0407020M0BBACA3
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 35mg/3.5ml solution for injection ampoules
0407020M0BBADAT
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/2ml solution for injection ampoules
0407020M0BBAHA6
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/5ml solution for injection ampoules
0407020M0BBAEAN
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Synastone 10mg/1ml solution for injection ampoules
0407020M0BCAAAV
|
Synastone | Methadone hydrochloride | Central Nervous System | No data available |
|
Synastone 50mg/1ml solution for injection ampoules
0407020M0BCABAC
|
Synastone | Methadone hydrochloride | Central Nervous System | No data available |
|
Synastone 50mg/2ml solution for injection ampoules
0407020M0BCACA6
|
Synastone | Methadone hydrochloride | Central Nervous System | No data available |
|
Synastone 50mg/5ml solution for injection ampoules
0407020M0BCADAN
|
Synastone | Methadone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.